NCT06891157
- Conditions
- Chidamide, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +8 more
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
Clinical trial condition
Chidamide
Explore clinical trials studying Chidamide. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Chidamide trial results
Not Yet Recruiting
Application of PD-1 Inhibitors, Tenofovir, Chidamide, and Lenalidomide in Relapsed/Refractory EBV-associated Lymphoproliferative Disorders.
NCT07133763
- Conditions
- Chidamide, EBV-Associated Lymphoproliferative Disorders, Lenalidomide, +2 more
- Locations
-
Not specified
Not Yet Recruiting
Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.
NCT07133776
- Conditions
- Chidamide, DNA Virus Infections, Epstein-Barr Virus (EBV) Infection, +8 more
- Locations
-
Not specified